Emergency Use Authorisation for the Merck drug Molnupiravir — an oral antiviral medicine for the treatment of mild-to-moderate COVID-19 — is likely “within days”, Dr Ram Vishwakarma, Chairman of the Covid Strategy Group, CSIR, told NDTV on Wednesday. The medicine is meant for adults who are at risk for progressing to severe COVID-19 or hospitalization. Another pill from Pfizer, Paxlovid, may take some more time, he added.
The two drugs, he said, will make a difference and “as we move from pandemic to endemic, these are the ones which are going to be more important than vaccination”.
India on Wednesday recorded 11,466 new COVID-19 cases in the last 24 hours, taking the active caseload to 1,39,683. Active coronavirus cases in India currently stand at 0.41%, the lowest since March 2021.
Here are the LIVE Updates on Coronavirus Cases In India:
COVID-19 has been detected in a pet dog in the United Kingdom, confirmed UK’s Chief Veterinary Officer in a statement on Wednesday.
According to him, the infection was confirmed following tests at the Animal and Plant Health Agency (APHA) laboratory in Weybridge on November 3. The dog is now recovering at home.
All available evidence suggests that the dog contracted the coronavirus from its owners who had previously tested positive for coronavirus. There is no evidence to suggest that the animal was involved in the transmission of the disease to its owners or that pets or other domestic animals are able to transmit the virus to people, according to the statement.